Evidence map›Paper›PMID 39329826›Full record

ArticleBiosensors2024

Improved Glycemic Control during a One-Week Adventure Camp in Adolescents with Type 1 Diabetes-The DIACAMP Study.

Antonia-Therese Kietaibl, Faisal Aziz, Eva Wurm, Celine Tomka, Elke Fröhlich-Reiterer, Othmar Moser, Thomas R Pieber, Peter Fasching, Julia K Mader, Harald Sourij and 1 more

Abstract read
In one paragraph

Article in Biosensors, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. We Are Not Alone: Examining the Impact of a Teen Diabetes Day Camp.Behavioral sciences (Basel, Switzerland) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Antonia-Therese KietaiblDepartment of 5th Internal Medicine with Endocrinology, Rheumatology and Gerontology, Clinic Ottakring, 1160 Vienna, Austria.
Faisal AzizDivision of Endocrinology and Diabetology, Medical University of Graz, 8036 Graz, Austria.
Eva WurmDivision of Internal Medicine, Diakonissen Hospital Schladming, 8970 Schladming, Austria.
Celine TomkaDivision of Endocrinology and Diabetology, Medical University of Graz, 8036 Graz, Austria.ORCID 0009-0001-8980-6793
Elke Fröhlich-ReitererDepartment of Pediatrics and Adolescent Medicine, Medical University of Graz, 8036 Graz, Austria.
Othmar MoserDivision of Endocrinology and Diabetology, Medical University of Graz, 8036 Graz, Austria.
Thomas R PieberDivision of Endocrinology and Diabetology, Medical University of Graz, 8036 Graz, Austria.ORCID 0000-0003-3554-0405
Peter FaschingDepartment of 5th Internal Medicine with Endocrinology, Rheumatology and Gerontology, Clinic Ottakring, 1160 Vienna, Austria.ORCID 0000-0003-1709-1079
Julia K MaderDivision of Endocrinology and Diabetology, Medical University of Graz, 8036 Graz, Austria.ORCID 0000-0001-7854-4233
Harald SourijDivision of Endocrinology and Diabetology, Medical University of Graz, 8036 Graz, Austria.ORCID 0000-0003-3510-9594
Felix AbererDivision of Endocrinology and Diabetology, Medical University of Graz, 8036 Graz, Austria.ORCID 0000-0002-9947-1413

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Adolescence remains a crucial age associated with diabetes distress in individuals living with type 1 diabetes (T1D). The Austrian organization "Diabär" regularly hosts a one-week adventure camp for adolescents (12-18 years) living with T1D. The camp focuses on "fun activities" without a structured educational protocol in order to minimize diabetes distress and increase diabetes management skills. In contrast to educational camps, training is kept to a minimum. However, attendees analyze the glycemic data of the previous day with their medical supervisor once daily during the camp. All subjects used a standardized real-time continuous glucose monitoring (CGM) system (DexcomG7) throughout the whole study. Glycemic metrics were prospectively analyzed during three periods: week 1 = home phase, week 2 = adventure camp, and week 3 = after the camp. Safety (time below range 1 [TBR1], 69-54 mg/dL, and time below range 2 [TBR2], <54 mg/dL) and efficacy (time in range [TIR], 70-180 mg/dL) were assessed by comparing the CGM data during weeks 1-3. The CGM data of 14 participants were analyzed. The TIR was higher during the camp week versus week 1 (70.4 ± 11.1% vs. 53.1 ± 20.2%;

Indexed as

Blood GlucoseDiabetes Mellitus, Type 1Glycemic ControlAdolescentBlood Glucose Self-MonitoringChildFemaleHumansMaleBlood Glucosecontinuous glucose monitoringdiabetes campdiabetes mellitus type 1

Identifiers

PMID39329826
PMCPMC11430097

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.